Successful treatment of Ochroconis gallopavum infection in an immunocompetent host

J W Hollingsworth1, S Shofer, A Zaas

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Box 3136, Durham, NC 27710, USA. holli017@mc.duke.edu

Infection
|August 22, 2007
PubMed

Insights

Ochroconis gallopavum, a fungus, rarely causes disease in immunocompromised individuals. This study details the first reported pulmonary infection in an immunocompetent host, successfully treated with oral antifungals.

Area of Science:

  • Medical Mycology
  • Infectious Diseases

Background:

  • Ochroconis gallopavum is a dematiaceous fungus.
  • It is an infrequent cause of disease in immunocompromised patients.
  • The fungus has also been implicated in epidemic encephalitis in poultry.

Observation:

  • This report details the first documented case of active Ochroconis gallopavum pulmonary infection.
  • The patient was an immunocompetent host, challenging the typical understanding of O. gallopavum pathogenicity.
  • The infection presented with pulmonary symptoms.

Findings:

  • The pulmonary infection in the immunocompetent host showed a rapid and complete response to oral antifungal therapy.
  • This suggests a potential treatment avenue for Ochroconis gallopavum infections, even in non-immunocompromised individuals.
  • The specific antifungal agent and dosage led to complete resolution.

Implications:

  • This case expands the known clinical spectrum of Ochroconis gallopavum infections.
  • It highlights the possibility of O. gallopavum causing disease in immunocompetent individuals.
  • Successful treatment with oral antifungals offers a promising therapeutic strategy for similar future cases.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...